Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-009946
Filing Date
2025-05-13
Accepted
2025-05-13 16:10:43
Documents
45
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 649087
2 EX-31.1 ex31-1.htm EX-31.1 13941
3 EX-31.2 ex31-2.htm EX-31.2 14029
4 EX-32.1 ex32-1.htm EX-32.1 7505
5 EX-32.2 ex32-2.htm EX-32.2 7268
  Complete submission text file 0001641172-25-009946.txt   3880566

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE bfrg-20250331.xsd EX-101.SCH 33153
7 XBRL CALCULATION FILE bfrg-20250331_cal.xml EX-101.CAL 29048
8 XBRL DEFINITION FILE bfrg-20250331_def.xml EX-101.DEF 143148
9 XBRL LABEL FILE bfrg-20250331_lab.xml EX-101.LAB 339529
10 XBRL PRESENTATION FILE bfrg-20250331_pre.xml EX-101.PRE 236317
47 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 493037
Mailing Address 325 ELLINGTON BLVD. UNIT 317 GAITHERSBURG MD 20878
Business Address 325 ELLINGTON BLVD. UNIT 317 GAITHERSBURG MD 20878 3013672055
BullFrog AI Holdings, Inc. (Filer) CIK: 0001829247 (see all company filings)

EIN.: 844786155 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41600 | Film No.: 25940179
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)